causal
Moderna Pursued Parallel Platform Applications
Moderna's strategy was to develop mRNA technology in parallel across rare diseases, oncology, and vaccines, because early on the engineering benefits were clearer than the medical ones, and vaccines were chosen as the straightest path to proving pharmacology.
causalpending
Speaker
Tal ZaksEvidence Quote
“when it was clear early on that vaccine was the straightest shot to proving pharmacology of this technology, we went after vaccines. We didn't drop the other elements”
Created: 11/19/2026, 4:01:33 PM
Your notes
Loading notes...